Interim Results From the IMPACT Study: Evidence for Prostate-Specific Antigen Screening in BRCA2 Mutation Carriers

European Urology - Netherlands
doi 10.1016/j.eururo.2019.08.019
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV

Related search

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Intensive Breast Screening in BRCA2 Mutation Carriers Is Associated With Reduced Breast Cancer Specific and All Cause Mortality

Hereditary Cancer in Clinical Practice
OncologyGenetics
2016English

The Role of Prostate-Specific Antigen in Prostate Cancer Screening

Romanian Review of Laboratory Medicine
2014English

Prostate Cancer Screening in BRCA and Lynch Syndrome Mutation Carriers

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2013English

Recommendations on Screening for Prostate Cancer With the Prostate-Specific Antigen Test

CMAJ
Medicine
2014English

Overdetection, Overtreatment and Costs in Prostate-Specific Antigen Screening for Prostate Cancer

British Journal of Cancer
Cancer ResearchOncology
2009English

Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis

Breast Diseases
OncologySurgery
2013English

Managing Localized Prostate Cancer in the Era of Prostate-Specific Antigen Screening

Cancer
Cancer ResearchOncology
2013English

Uterine Cancer in Jewish Israeli BRCA1/BRCA2 Mutation Carriers

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy